Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by FredTheVoiceon Mar 16, 2021 3:54pm

187 Views

Post# 32809757

The sector will see some money...more and more...

https://www.lapresse.ca/affaires/entreprises/2021-03-16/ottawa-allonge-100-millions-pour-trois-entreprises-biomedicales.php

In Canada, we just announced 100M of investiment in biopharma...

And the minister is promising more money soon.

With the money following vaccination and COVID traitment, we should see in the next year a period of merger and acquisition.

Lets see what that will mean for TH.

FTV.

<< Previous

Bullboard Posts

Next >>

Venture-listed mining stock reports promising drill results from Peru